Alexander Nolte

Insider Reports History

Location
Waltham, MA
Signature
/s/ Brian J. Shea, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alexander Nolte:

Company Role Class Num Shares Value Price $ Report Date Ownership
Syndax Pharmaceuticals Inc Chief Accounting Officer Stock Options (Right to buy) 17,000 $328,950 $19.35 02 Feb 2023 Direct
Syndax Pharmaceuticals Inc Chief Accounting Officer Common Stock 0 $18.27 01 Feb 2022 Direct

Insider Reports Filed by Alexander Nolte

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ONCR Oncorus, Inc. 09 May 2023 0 $0 3 Interim CFO 22 May 2023, 17:00
SNDX Syndax Pharmaceuticals Inc 02 Feb 2023 1 +$485,350 4 Chief Accounting Officer 03 Feb 2023, 15:58
SNDX Syndax Pharmaceuticals Inc 01 Feb 2022 3 +$469,576 4 Chief Accounting Officer 03 Feb 2022, 16:31
SNDX Syndax Pharmaceuticals Inc 22 Oct 2021 0 $0 3 Chief Accounting Officer 04 Nov 2021, 16:03